Stockreport

TG Therapeutics Provides Business Update and Reports First Quarter 2024 Financial Results

TG Therapeutics, Inc.  (TGTX) 
Last tg therapeutics, inc. earnings: 11/12 07:34 am Check Earnings Report
US:NASDAQ Investor Relations: ir.tgtherapeutics.com
PDF First quarter 2024 BRIUMVI U.S. net revenue of $50.5 million, representing 25% quarter over quarter growth Total revenue for Q1 2024 of $63.5 million, including a $12.5 [Read more]